CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP R&D, Chief Medical Officer sold 9,000 shares at $29.72 ($267,485)
- 4 Planned sale EVP, CLO, Alkermes, Inc. sold 4,068 shares at an average $29.53 ($120,108)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes VP, Finance (Interim PAO) gave up 808 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 2,403 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,695 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 3,049 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 3,049 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Finance (Interim PAO) gave up 672 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 2,845 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,880 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 3,414 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 3,414 shares (to pay taxes)
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 5 of 97 · 1,927 filings